www.360dx.com Open in urlscan Pro
2606:4700::6812:1c43  Public Scan

Form analysis
2 forms found in the DOM

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

Text Content

Skip to main content


SISTER PUBLICATION LINKS

 * GenomeWeb
 * 360Dx
 * Precision Oncology News

 * RSS Feeds
 * Visit 360Dx on Twitter
 * Visit 360Dx on LinkedIn

Premium Trial:

Request an Annual Quote


USER ACCOUNT MENU

 * My 360Dx
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out

Log in
Subscribe
Menu
Close Menu


MAIN NAVIGATION

 * My 360Dx
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out
 * Business & Policy
   * Business News
   * Research Funding
   * Policy & Legislation
   * Regulatory News
   * Reimbursement
 * Clinical Lab Management
 * Diagnostics
   * Molecular Diagnostics
   * Immunoassays
   * Tissue-Based Testing
   * Clinical Chemistry
   * Hematology/Coagulation
   * Point-of-Care Testing
   * Companion Diagnostics
 * Disease Areas
   * Cancer
   * Infectious Disease
   * Cardiovascular Disease
   * Neurological & Psychological Disease
   * Autoimmune Disease
   * Inherited Disease
   * Reproductive Health
   * Respiratory
   * Gastrointestinal
   * COVID-19
 * Resources
   * Webinars
   * White Papers
   * Job Listings
   * New Products
   * People in the News
   * Coronavirus Test Tracker
   * Partner Content





BREADCRUMB

 1. Home
 2. Business, Policy & Funding
 3. Regulatory News & FDA Approvals

Premium Trial:

Request an Annual Quote

Log in
Subscribe



BECTON DICKINSON GETS FDA 510(K) CLEARANCE FOR HIGH-THROUGHPUT VAGINITIS TEST

Mar 16, 2023 | staff reporter
Save for later

NEW YORK – Becton Dickinson announced on Thursday that it received 510(k)
clearance from the US Food and Drug Administration for a high-throughput assay
to detect vaginitis.

The assay, called the BD Vaginal Panel, runs on the firm's BD Cor System and
tests for the three most common pathogens that cause vaginitis using a single
swab sample.

The vaginitis panel was originally launched in 2016 for use on the BD Max
System, but the BD Vaginal Panel assay on the BD Cor is the first
high-throughput version of the test, the Franklin Lakes, New Jersey-based firm
noted in a statement.

The fully integrated BD Cor System allows 1,700 specimens to be loaded at a
time, has onboard capacity for reagents and samples that provides eight hours of
uninterrupted system processing, and can deliver approximately 2,000 results in
24 hours.

The panel detects and distinguishes bacterial vaginosis, Trichomonas vaginalis,
and vulvovaginal candidiasis, commonly known as a yeast infection. The panel is
also the only FDA-cleared test to provide separate results for Candida glabrata
and C. krusei, as these two species are known to carry resistance to common
antimicrobials, BD said.

Accurate diagnosis of these pathogens ensures appropriate treatment and
decreases the risk of complications and resistance to treatment, BD said, and
the use of a single test reduces repeat testing, unnecessary treatments, and the
risk of contracting sexually transmitted infections due to lingering vaginitis
symptoms.

"Most women have a vaginal infection during their lifetime, and millions of them
receive inadequate treatment," said Nikos Pavlidis, VP of diagnostics for BD,
citing a recent study that showed 40 percent of women did not receive the
appropriate diagnosis and treatment for vaginitis after an initial physician
visit.

"The BD Vaginal Panel can help end the cycle of repeat visits, misdiagnosis, and
ineffective treatment for the millions of women suffering from vaginitis,"
Pavlidis said.

The BD Vaginal Panel is the third assay available for use on the BD Cor System
in the US, in addition to the BD Onclarity HPV assay with extended genotyping
and the BD CTGCTV2 molecular assay that detects Chlamydia trachomatis, Neisseria
gonorrhoeae, and T. vaginalis.

With the clearance of the BD Vaginal Panel on the BD Cor System, labs can now
offer physicians both BD Vaginal Panel and BD CTGCTV2 testing from one swab and
one patient collection, BD said.


TO READ THE FULL STORY…

Register for Free.

…and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb or Precision Oncology News account?

Login Now



FILED UNDER

Regulatory News & FDA Approvals
Molecular Diagnostics
PCR
Infectious Disease
Reproductive Health
women's health
Becton Dickinson
North America
510(k)
FDA clearance


WE RECOMMEND

 1. Becton Dickinson Gets FDA 510(k) Clearance for High-Throughput Vaginitis
    Test
    staff reporter, GenomeWeb, 2023
 2. Becton Dickinson High-Throughput MDx Module, Triplex STI Test Get FDA
    510(k)Clearance
    staff reporter, GenomeWeb, 2022
 3. Becton Dickinson Expanding High-Throughput BD Cor Menu After US Launch
    Madeleine Johnson, GenomeWeb, 2021
 4. BD High-Throughput MDx System CE Marked
    360Dx, 2019

 1. Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test
    staff reporter, GenomeWeb, 2022
 2. FDA Approves BD High-Throughput Cor System, HPV Screening Assay
    staff reporter, GenomeWeb, 2021
 3. Becton Dickinson Strengthens Position in Women's Health, STI Testing With
    New FDA Approvals
    Madeleine Johnson, 360Dx, 2016
 4. FDA Clears BD Vaginal Pathogen Panel
    staff reporter, 360Dx, 2016

Powered by
 * Privacy policy
 * Do not sell my personal information
 * Google Analytics settings


I consent to the use of Google Analytics and related cookies across the TrendMD
network (widget, website, blog). Learn more
Yes No


Breaking News


 * GUARDANT HEALTH, OHIO STATE UNIVERSITY PARTNER ON BLOOD-BASED COLON CANCER
   SCREENING STUDY


 * INVITAE, EPIC SIGN DEAL TO INTEGRATE GENETIC TEST RESULTS INTO EMR SYSTEM


 * LUMIRADX Q4 REVENUES FALL 65 PERCENT


 * VITESTRO RAISES €12 MILLION IN SERIES A ROUND


 * CUE HEALTH GETS FDA EUA FOR MONKEYPOX MOLECULAR TEST


 * DIASORIN GETS FDA 510(K) FOR MOLECULAR COVID-19/FLU ASSAY



What's Popular?


 1. DIASORIN GETS FDA 510(K) FOR MOLECULAR COVID-19/FLU ASSAY


 2. MASSACHUSETTS LAB OWNER INDICTED ON CHARGES OF URINE DRUG TESTING FRAUD


 3. LABCORP ACQUIRING ENZO BIOCHEM'S CLINICAL LAB BUSINESS FOR $146M


 4. DUTCH RESEARCHERS CRAFT GLOW-IN-THE-DARK POC INFECTIOUS DISEASE TEST
    PREMIUM


 5. TOP FIVE ARTICLES ON 360DX LAST WEEK: FDA REGULATION OF LDTS; VISBY FDA
    CLEARANCE; AND MORE




SPONSORSHIPS





FOOTER

 * About us
 * Advertise
 * Contact
 * FAQ
 * Jobs
 * Sitemap
 * Submit A Tip

Subscribe

Privacy Policy.  Terms & Conditions. Copyright © 2023 GenomeWeb, a business unit
of Crain Communications.  All Rights Reserved.

Our site uses cookies and related technologies, as described in our 
Datenschutzerklärung, for purposes that may include site operation, analytics,
enhanced user experience, or advertising. You may choose to consent to our use
of these technologies or manage your own preferences.
Akzeptieren Ablehnen Einstellungen verwalten



AddThis Sharing Sidebar
Share to EmailEmailShare to Copy LinkCopy LinkShare to PrintPrintShare to
TwitterTwitterShare to LinkedInLinkedInMore AddThis Share optionsAddThis
Hide
Show
Close

AddThis

AddThis Sharing
EmailCopy LinkPrintTwitterLinkedInAddThis